FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Realm US

12,852 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 10,871

 

Start Prev Rows 8000 - 8200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
signal.core.r4R4questionnaire-dacods-transfer-referral-sourceQuestionnaire DACODS Transfer Referral Sourcedraft1pahl7
signal.core.r4R4questionnaire-dacods-clinician-diagnostic-impressionQuestionnaire DACODS Clinician Diagnostic Impressiondraft1pahl7
signal.core.r4R4questionnaire-dacods-medical-physical-problemsQuestionnaire DACODS Medical Physical Problemsdraft1pahl7
signal.core.r4R4questionnaire-dacods-education-employment-problemsQuestionnaire DACODS Education Employment Problemsdraft1pahl7
signal.core.r4R4questionnaire-dacods-family-issues-and-problemsQuestionnaire DACODS Family Issues And Problemsdraft1pahl7
signal.core.r4R4questionnaire-dacods-socialization-problemsQuestionnaire DACODS Socialization Problemsdraft1pahl7
us.cdc.phinvadsR42.16.840.1.113883.3.520.4.27NAACCR TNM Pathologic Staged By (NAACCR)active2015-01oid
signal.core.r4R4questionnaire-dacods-source-of-payment-for-treatmentQuestionnaire DACODS Source Of Payment For Treatmentdraft1pahl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.3291Immunization Profile Identifier (IIS)active2015-01oid
signal.core.r4R4identifier-useIdentifierUsedraft0fhir2019-10hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.7831Evaluation Status Reason (IIS)active2018-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3292Immunization Schedule Identifier (IIS)active2010-01oid
signal.core.r4R4questionnaire-dacods-sexual-orientationQuestionnaire DACODS Sexual Orientationdraft1pahl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7450Vaccine Event Information Source (NND)active2019-01sct tho oid
hl7.fhir.us.insurance-cardR4C4DICCoverageIdentifierTypeC4DIC Coverage Identifier Typeactiveclaims2024-04hl7fhir tho
hl7.fhir.us.carin-bbR4C4BBPatientIdentifierTypeC4BB Patient Identifier Type Value Settrial-usefm2025-02hl7fhir tho
hl7.fhir.us.carin-bbR4C4BBOrganizationIdentifierTypeC4BB Organization Identifier Type Value Settrial-usefm2025-02hl7fhir tho
hl7.fhir.us.carin-bbR4C4BBPractitionerIdentifierTypeC4BB Practitioner Identifier Type Value Settrial-usefm2025-02hl7tho
hl7.fhir.us.carin-bbR4C4BBPayeeTypeC4BB Payee Type Value Settrial-usefm2025-02hl7fhir tho
us.nlm.vsacR42.16.840.1.113762.1.4.1237.22Medicinal Ingredients RXNORMactive2024-01hl7rx
signal.core.r4R4questionnaire-dacods-tobacco-useQuestionnaire DACODS Tobacco Usedraft1pahl7
hl7.fhir.us.mcodeR4mcode-tnm-regional-nodes-staging-type-vsTNM Regional Nodes Staging Type Value Setactive4cic2025-02hl7sct
hl7.fhir.us.mcodeR4mcode-tnm-stage-group-staging-type-vsTNM Stage Group Staging Type Value Setactive4cic2025-02hl7sct
hl7.fhir.us.mcodeR4mcode-tnm-distant-metastases-staging-type-vsTNM Distant Metastases Staging Type Value Setactive4cic2025-02hl7sct
hl7.fhir.us.mcodeR4mcode-tnm-primary-tumor-staging-type-vsTNM Primary Tumor Staging Type Value Setactive4cic2025-02hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7540Blood Productactive2016-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.983Sites of Directly Observed Therapy (TB)active2008-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7868Type of Long Term Care Facility (C. auris)active2019-01cdc tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7890Treatment Site (CO)active2019-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.997HIV Diagnosis Based Onactive2008-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7975Specimen Source Site (Leptospirosis)active2020-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7676Strain Type (Trich)active2018-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7833Complications (TBRD)active2018-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7487Reason for Hospitalization (VZ)active2016-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.969Case investigation closure reasonactive2008-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7495Serotype (Arbovirus)active2016-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3287Immunization Funding Source (IIS)active2016-01oid
fhir.argonaut.r2R2vacc-statusArgonaut Immunization Statusdraft2016-10hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.3060Immunosuppressed Conditionactive2019-01sct
hl7.fhir.us.vdorR4nvdrs-document-types-vsNVDRS Document Typesinformativepher2025-06hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.7640Improper Handling Storage (FDD)active2017-01tho oid
hl7.fhir.us.davinci-pasR4pas-pwk01-attachment-report-type-codePAS PWK01 Attachment Report Type Code Value Settrial-use3fm2024-05hl7x12
hl7.fhir.us.davinci-cdexR4cdex-pwk01-attachment-report-type-codeCDex PWK01 Attachment Report Type Code Value Settrial-use2claims2024-05hl7x12
fhir.cqf.commonR4inactive-conditionCQF Inactive Conditionactive2019-07hl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1095.85Nutrition Diagnosis Groupingactive2024-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1095.70Nutrition Education SNOMED CTactive2020-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1095.82Food and Nutrition Related History Groupingactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1248.241Degenerative Neurological Disorderactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1248.239Neuromuscular Disorderactive2023-09hl7vsac
hl7.fhir.us.registry-protocolsR4NewYorkHeartAssociationNew York Heart Association Assessment Scaleactivecic2023-11hl7sct loinc
hl7.fhir.us.pacio-adiR4ADINoHealthcareAgentIncludedReasonVSNo Healthcare Agent Included Reasonactivepe2025-07hl7tho
fhir.cdc.opioid-cds-r4R4medicationrequest-category-communityValueSet - Medication Request Category Communityactive2025-07hl7
hl7.fhir.us.mcodeR4mcode-cancer-related-surgical-procedure-vsCancer-Related Surgical Procedure Value Setactive3cic2025-02hl7sct cpt cms
us.cdc.phinvadsR42.16.840.1.114222.4.11.7961Medication (Leptospirosis)active2020-01sct rx tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7751Type of Link (TB)active2017-12tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7860Medication Administered Relative to Treatment (Malaria)active2018-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.8034Medication Duration Unit (Hansen)active2021-01ucum
us.cdc.phinvadsR42.16.840.1.114222.4.11.8033Frequency Duration Unit (Hansen)active2021-01ucum tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7955Location of Initial Diagnosis (Hansen)active2020-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7980Patient Case Status (Hansen)active2020-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7651Previous Case Diagnosed By (Rubella)active2017-01sct tho
hl7.fhir.us.vdorR4vdor-drug-misuse-vsVDOR Indicated Prescription Drug Misuse or Illicit Drug Useinformativepher2025-06hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.3288Vaccination Contraindication (IIS)active2010-01sct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.981Diagnosed Pneumonia By (VZ)active2008-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.968Case Classification Statusactive2008-01sct tho oid
hl7.fhir.us.carin-bbR4C4BBInstitutionalClaimSubTypeC4BB Institutional Claim SubType Value Settrial-usefm2025-02hl7fhir
hl7.fhir.us.carin-bbR4C4BBClaimInpatientInstitutionalDiagnosisTypeC4BB Claim Inpatient Institutional Diagnosis Type Value Settrial-usefm2025-02hl7fhir tho
hl7.fhir.us.carin-bbR4C4BBClaimProcedureTypeC4BB Claim Procedure Type Value Settrial-usefm2025-02hl7fhir
hl7.fhir.us.carin-bbR4C4BBClaimOutpatientInstitutionalDiagnosisTypeC4BB Claim Outpatient Institutional Diagnosis Type Value Settrial-usefm2025-02hl7fhir tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3304Parotitis Laterality (Mumps)active2010-01sct tho
hl7.fhir.us.carin-bbR4C4BBClaimProfessionalAndNonClinicianDiagnosisTypeC4BB Claim Professional And Non Clinician Diagnosis Type Value Settrial-usefm2025-02hl7fhir tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3039Isolate Availability EIP Testingactive2008-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7244History of Disease as Evidence Of Immunity (IIS)active2018-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7245Serological Evidence Of Immunity (IIS)active2014-01sct
hl7.fhir.us.carin-bbR4C4BBClaimIdentifierTypeC4BB Claim Identifier Type Value Settrial-usefm2025-02hl7fhir
hl7.fhir.us.davinci-pctR4PCTPayerProviderNetworkStatusVSPCT Payer Provider Network Statustrial-usefm2025-06hl7fhir
hl7.fhir.us.davinci-pdexR4PriorAuthServiceTypeCodesPrior Authorization Service Type Codes (X12)informativefm2025-06hl7x12
us.cdc.phinvadsR42.16.840.1.114222.4.11.7982Vaccine Exposure (Brucellosis)active2020-01sct tho
hl7.fhir.us.davinci-pctR4PCTPayerBenefitPaymentStatusVSPCT Payer Benefit Payment Statustrial-usefm2025-06hl7fhir
hl7.fhir.us.carin-bbR4C4BBPayerBenefitPaymentStatusC4BB Payer Benefit Payment Status Value Settrial-usefm2025-02hl7fhir
hl7.fhir.us.davinci-pdexR4PDexPayerBenefitPaymentStatusPDex Payer Benefit Payment Statusinformativefm2025-06hl7fhir
signal.core.r4R4questionnaire-dacods-discharge-statusQuestionnaire DACODS Discharge Statusdraft1pahl7
signal.core.r4R4questionnaire-dacods-reason-for-dischargeQuestionnaire Dacods Reason For Dischargedraft2023-09hl7
signal.core.r4R4questionnaire-ccars-reason-for-dischargeQuestionnaire CCARS Reason For Dischargedraft1pahl7
hl7.fhir.us.carin-bbR4C4BBPayerProviderNetworkStatusC4BB Payer Provider Network Status Value Settrial-usefm2025-02hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.7158State or Province of Exposureactive2013-01iso oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.8035Subject of Medication Received (Hansen)active2021-01sct tho
hl7.fhir.us.davinci-pctR4PCTAEOBProcessNoteVSPCT AEOB Process Note Typestrial-usefm2025-06hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.7990Specimen Type (Anthrax)active2020-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3267Non-Sterile Specimen (Pediatric Flu)active2009-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3264Sterile Specimen (Pediatric Flu)active2009-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7383Death Reporting Event Reason (NCHS)active2014-12oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7969Specimen Type (Brucellosis)active2020-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7974Specimen Type (Leptospirosis)active2020-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.964Adverse Event Previously Reportedactive2008-01tho
signal.core.r4R4location-modeLocationModetrial-use3pa2019-10hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.957Abnormal Chest X-Ray Finding (TB)active2008-01tho oid
signal.core.r4R4account-statusAccountStatustrial-use2pa2019-10hl7fhir
hl7.fhir.us.carin-bbR4C4BBPayerClaimPaymentStatusCodeC4BB Payer Claim Payment Status Code Value Settrial-usefm2025-02hl7fhir
signal.core.r4R4location-statusLocationStatustrial-use3pa2019-10hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.980Diagnosed by (VZ)active2017-01tho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1222.580NYHA Heart Failure Functional Classificationsactive2024-09hl7sct
hl7.fhir.us.breastcancerR3cimi-context-DeltaFlagVSBC DeltaFlagVS ValueSetdraft2018-08hl7sct
hl7.fhir.us.directory-queryR4IndividualSpecialtyAndDegreeLicenseCertificateVSIndividual Specialties, Degrees, Licenses, and Certificates Value Setactive2022-12hl7tho
hl7.fhir.us.davinci-pdex-plan-netR4IndividualSpecialtyAndDegreeLicenseCertificateVSIndividual Specialties, Degrees, Licenses, and Certificates VStrial-usefm2025-02hl7fhir tho
hl7.fhir.us.ndhR4IndividualSpecialtyAndDegreeLicenseCertificateVSIndividual Specialties, Degrees, Licenses, and Certificates Value Settrial-usepa2025-07hl7fhir tho
hl7.fhir.us.directory-queryR4IndividualAndGroupSpecialtiesVSIndividual and Group Specialtiesactive2022-12hl7nucc
hl7.fhir.us.davinci-pdex-plan-netR4IndividualAndGroupSpecialtiesVSIndividual and Group Specialtiestrial-usefm2025-02hl7nucc
hl7.fhir.us.ndhR4IndividualAndGroupSpecialtiesVSIndividual and Group Specialtiestrial-usepa2025-07hl7nucc
fhir.cdc.opioid-cds-r4R4non-opioid-urine-drug-screeningNon-opioid drug urine screeningactive2023-05hl7loinc
fhir.cdc.opioid-cds-r4R4opioid-urine-drug-screeningOpioid drug urine screeningactive2023-05hl7loinc
fhir.cdc.opioid-cds-r4R4xylazine-urine-drug-screening-testsXylazine drug urine screening testsactive2024-05hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1095.2Food and Nutrient Delivery SNOMED CTactive2025-05hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.945Industry (SIC)active2008-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.8057Infant Anti-HCVTest Result (Hepatitis C Perinatal)active2021-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.8045Infant HCV Antigen Test Result (Hepatitis C)active2021-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.8044Infant Nucleic Acid Test Result (Hepatitis C)active2021-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3123Birth Outcome (VPD)active2008-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3122Birth Location (VPD)active2008-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.6070Infections During Pregnancy - Live Birth (NCHS)active2017-01sct tho
us.nlm.vsacR42.16.840.1.113762.1.4.1096.227Findings Related to Medication Management, Infectious Disease Symptomsactive2021-03hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3250Vaccines Administered (Flu)active2009-01cvx
us.cdc.phinvadsR42.16.840.1.114222.4.11.3273Vaccines Administered (Pediatric Flu)active2009-01cvx
signal.core.r4R4questionnaire-ccars-current-living-arrangementQuestionnaire CCARS Current Living Arrangementdraft1pahl7
us.nlm.vsacR42.16.840.1.113762.1.4.1010.7Clinical Drug Ingredientactive2024-06hl7rx
hl7.fhir.us.pacio-adiR4ADIInitialTreatmentPMOOptionsVSInitial Treatment Portable Medical Order Optionsactivepe2025-07hl7vsac
fhir.virtually.healthcareR4BARSReferralCodeBARS Referral Codedraft2025-07hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3130Injury Type (VPD)active2008-01sct tho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1032.308Cardiovascular disease 10Y riskactive2024-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1021.41MDP Test HL7 Intensionalactive2019-01hl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1032.266Rhabdomyolysis Intensionalactive2024-06hl7sct
hl7.fhir.us.vrdrR4vrdr-intentional-reject-vsIntentional Reject ValueSetactivepher2024-10hl7fhir
hl7.fhir.us.mcodeR4mcode-rhabdomyosarcoma-clinical-group-value-vsRhabdomyosarcoma Clinical Group Valueactivecic2025-02hl7ncit sct
hl7.fhir.us.breastcancerR3shr-core-PositiveNegativeEquivocalIndeterminateVSBC PositiveNegativeEquivocalIndeterminateVS ValueSetdraft2018-08hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7615Pre-Pregnancy SerologicalTestInterp (CRS)active2017-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7476Positive Negative Equivocal Not Doneactive2016-01sct
hl7.fhir.us.breastcancerR3oncology-RecurrenceRiskScoreInterpretationVSBC RecurrenceRiskScoreInterpretationVS ValueSetdraft2018-08hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.7822Lab Test Type (Legionellosis)active2018-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7336Lab Test Type (Mumps)active2018-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7821Lab Test Type (Psittacosis)active2018-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7844Lab Test Type (Lyme)active2018-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7661Lab Test Type (Measles)active2019-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7337Lab Test Type (Pertussis)active2018-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.3300Lab Test Procedure (Rubella)active2019-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7549Test Type (Syphilis)active2021-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.3256Time Frame (Daily Weekly)active2009-01sct
hl7.fhir.us.registry-protocolsR4InterventionTypesIntervention Typesactivecic2023-11hl7fhir sct
fhir.org.nz.ig.baseR4nz-residencyNZ Residency statusactive2025-06hl7
hl7.fhir.us.codex-radiation-therapyR4codexrt-radiotherapy-isotope-vsRadiotherapy Isotope Value Setactivecgp2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1221.189Infertility, Maleactive2024-04hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1221.190Infertility, Maleactive2024-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1221.191Infertility, Maleactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1222.1446Covid Toes (Toes and/or Fingers)active2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.193relatedconditions_COPD I10active2023-03hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.173Asthma I10active2025-05hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.102Suicide Attemptactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1248.94Oxygen Partial Pressure in Arterial Bloodactive2024-01hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1248.95Carbon Dioxide Partial Pressure in Arterial Bloodactive2024-01hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1248.96Arterial Blood pHactive2024-01hl7loinc
hl7.fhir.us.ccdaR41.3.6.1.4.1.12009.10.2.5LOINC Imaging Document Codesactivecgp2022-07hl7loinc
hl7.fhir.us.ccdaR42.16.840.1.113883.11.20.6.1ProcedureNoteDocumentTypeCodesactivecgp2018-05hl7loinc
hl7.fhir.us.ccdaR42.16.840.1.113883.11.20.8.1ProgressNoteDocumentTypeCodeactivecgp2018-05hl7loinc
hl7.fhir.us.pacio-adiR4LOINCPOLSTCPRAnswerListLOINC POLST CPR Answer Listactivepe2025-07hl7loinc
hl7.fhir.us.pacio-adiR4LOINCPOLSTInitialTxAnswerListLOINC POLST Initial Tx Answer Listactivepe2025-07hl7loinc
hl7.fhir.us.pacio-adiR4LOINCPOLSTMedAssistNutrAnswerListLOINC POLST Med assist nutr Answer Listactivepe2025-07hl7loinc
hl7.fhir.us.pacio-adiR4LOINCPOLSTDiscussPartAnswerListLOINC POLST discuss part Listactivepe2025-07hl7loinc
hl7.fhir.us.pacio-adiR4LOINCPOLSTReviewAnswerListLOINC POLST review Answer Listactivepe2025-07hl7loinc
hl7.fhir.us.registry-protocolsR4RoseDyspneaQRose Dyspnea Questionsactivecic2023-11hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.202Serum Creatinineactive2024-02hl7loinc
hl7.fhir.us.registry-protocolsR4SeattleAnginaAsSeattle Angina Answersactivecic2023-11hl7loinc
hl7.fhir.us.davinci-pasR4X12278DiagnosisInformationTypeX12 278 Diagnosis Information Typetrial-use3fm2025-07hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.635LP(a) Test_ICDactive2025-03hl7icd
us.cdc.phinvadsR42.16.840.1.114222.4.11.7755LTBI Drug Regimen (TB)active2018-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7866Lab Test Method (MDRO)active2019-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3358Lab Test Name (NND)active2010-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7278Lab Test Performed Modifier (CS)active2016-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3017Lab Test Result (PHLIP Flu)active2019-01nucc sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.6013Lab Test Type (Hepatitis)active2022-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.6014Lab Test Type Enzymes (Hepatitis)active2012-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.3016Lab Test Order (PHLIP Flu)active2019-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.4275Lab Result (Cancer Morphology)active2011-01sct
us.nlm.vsacR42.16.840.1.113762.1.4.1260.50MSI Highactive2023-11hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7892Lab Result (Candida auris)active2019-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7895Lab Result Carbapenem Resistant Enterobacteriaceactive2019-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4024Lab Result (Cysticercosis)active2019-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4067Lab Result (Nontuberculous Mycobacteria)active2019-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4276Lab Result (Pesticide)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7894Lab Test Name (Candida Auris)active2019-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7893Lab Test Name Carbapenem Resistant Enterobacteriaactive2019-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.8030Lab Test (Hansen)active2021-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7733Lab Test Method (RIBD)active2019-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.1004Ordered Testactive2020-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7472Lab Test Type (Arbovirus)active2018-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.8041Lab Test Type (Leptospirosis)active2021-01sct tho oid
hl7.fhir.us.coreR4us-core-laboratory-test-codesUS Core Laboratory Test Codestrial-use3cgp2022-11hl7loinc
fhir.cdc.opioid-cds-r4R4observation-category-laboratoryObservation Category Laboratoryactive2023-05hl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.1002Lab Test Result Nameactive2020-01loinc
hl7.fhir.us.breastcancerR3oncology-HER2byFISHVSInterpretationTestsVSBC HER2byFISHVSInterpretationTestsVS ValueSetdraft2018-08hl7loinc
hl7.fhir.us.breastcancerR3oncology-EstrogenReceptorInterpretationTestsVSBC EstrogenReceptorInterpretationTestsVS ValueSetdraft2018-08hl7loinc
hl7.fhir.us.breastcancerR3oncology-HER2byIHCInterpretationTestsVSBC HER2byIHCInterpretationTestsVS ValueSetdraft2018-08hl7loinc